An Observational Safety Evaluation of Patients Treated With the NEVO Sirolimus-eluting Coronary Stent.

Trial Profile

An Observational Safety Evaluation of Patients Treated With the NEVO Sirolimus-eluting Coronary Stent.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2013

At a glance

  • Drugs Everolimus; Sirolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms NEVO-II
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 24 Oct 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 20 Jul 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 16 Nov 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top